Advances Intermediates

Banshidhar Pharma capabilities include non-infringing synthetic route selection with respect to patents, processes and analytical validation, optimization and successful scale-up from bench to manufacturing. Production is undertaken in the state-of-the-art multi-purpose FDCA compliant manufacturing facility. In order to meet the regulatory requirements, molecule formation, isolation of API and their subsequent operations such as drying, milling, blending and packing are carried out in a facility having FDCA practices.

We offer 2 ready APIs regulatory across Diuretics, Anti-Hypertensive, CNS, Cardiovascular, Anti-diabetic segments with product which are now generic APIs Intermediates. We also have 3 molecules in the pipeline.

Product Name	CAS No.
Theo bromine	83-67-0
Para anisic alcohol	105-13-5
Meta phenoxy benzyl alcohol	13826-35-2
Meta amino benzoic acid ( MABA )	99-05-8
Para amino benzoic acid ( PABA )	150-13-0
Methoxy ethyl nitrobenzene	91-23-6
Phenyl ethyl methyl ether	3558-60-9
Methyl-2-[3-cayno-4-(2-methylpropoxy)Phenyl)-4-methyl-1,3-thiazole-5-carboxylate ( Febuxostate Ester )	923942-34-1
6-Bromo-3-hydroxy pyrazine-2-carboxamide	259793-88-9
Di-Ketone	125971-96-2
(+)-3-carbamomethyl-5-methyl gexanoic Acid ( CMH )	181289-15-6
R(-)3-Carbamomethyl-5-methyl hexanoic Acid ( RCMH )	181289-33-8